You are here: Home » News-CM » Companies » Results
Business Standard

Parenteral Drugs (India) reports standalone net loss of Rs 26.14 crore in the December 2019 quarter

Capital Market 

Sales decline 28.88% to Rs 7.24 crore

Net Loss of Parenteral Drugs (India) reported to Rs 26.14 crore in the quarter ended December 2019 as against net loss of Rs 25.25 crore during the previous quarter ended December 2018. Sales declined 28.88% to Rs 7.24 crore in the quarter ended December 2019 as against Rs 10.18 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales7.2410.18 -29 OPM %-40.88-22.30 -PBDT-31.04-26.70 -16 PBT-35.38-31.33 -13 NP-26.14-25.25 -4

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, February 12 2020. 15:15 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU